PTRN
Pattern Group Inc. Series A Common Stock
PTRN has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over PTRN overall, supported by stronger fundamentals and stronger modeled upside.
PTRN Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Stable | |
| Healthy |
PTRN's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
PTRN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 24x | $18.66 | -11% |
| Fair | 25x | $19.54 | -6.7% |
| Expensive | 27x | $20.44 | -2.5% |
| Current | 27x | $20.95 | — |
| Forward | 28x | $20.95 | — |
Historical ranges are pointers, not guarantees.
PTRN's PE is 27x, but its earnings don't support one, so it isn't a reliable read right now.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over PTRN in the historical PE scenario, which offers more potential upside but is not a forecast.
PTRN Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for PTRN, with profitability improving.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over PTRN on the outlook, with more favorable valuation expectations.
PTRN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.76 | -1.3% |
| Q3 2026 | $0.77 | +$2.68 |
| Q2 2026 | -$1.60 | -544% |
| Q1 2026 | -$1.66 | -603% |
| Q4 2025 | -$1.73 | -658% |
| Q3 2025 | -$1.91 | -782% |
PTRN has returned to profit: it earned $0.77 per share over the past year, after losing money the year before.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over PTRN in the latest year-over-year earnings comparison.
PTRN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $885.8M | +38% |
| Q2 2026 | $876.8M | +47% |
| Q1 2026 | $773.7M | +43% |
| Q4 2025 | $723.1M | +40% |
| Q3 2025 | $639.7M | +46% |
| Q2 2025 | $598.2M | +39% |
| Q1 2025 | $540.4M | +32% |
| Q4 2024 | $515.5M | +31% |
PTRN's revenue has grown year over year every quarter since late 2024: $886M last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.2% | +14 points |
| Q2 2026 | 4% | -1 points |
| Q1 2026 | 5.1% | -0.3 points |
| Q4 2025 | 3.6% | -0.9 points |
| Q3 2025 | -9.4% | -13 points |
| Q2 2025 | 5% | -0.3 points |
| Q1 2025 | 5.4% | -0.2 points |
| Q4 2024 | 4.5% | +0.5 points |
PTRN's operating margin was 4.2% last quarter, up 14 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over PTRN on profitability, with a higher operating margin.
PTRN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $3.8M | +$7.1M |
| Q1 2026 | $63.3M | +47% |
| Q2 2025 | -$3.3M | -1297% |
| Q1 2025 | $43.2M | +26% |
PTRN generated $106M in free cash flow over the past year, up 42% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK generated $17.4B in free cash flow over the past year, more than ten times what it generated the year before.
PTRN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +1.2M shares |
| 1 year | +79% | +80.7M shares |
PTRN has 182M diluted shares, up 79% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $18.4M |
| Q2 2026 | $94,000 |
| Q1 2026 | $3.6M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q2 2024 | — |
| Q1 2024 | — |
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over PTRN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
PTRN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.2x | Net Cash |
| Q2 2026 | -5.9x | Net Cash |
| Q1 2026 | -6.3x | Net Cash |
| Q4 2025 | -6.5x | Net Cash |
| Q3 2025 | -7.3x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.7x | Net Cash |
PTRN has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
PTRN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.7 | Neutral |
| Stochastic | 36.8 | Neutral |
PTRN's weekly RSI is 56 (neutral) and its Stochastic is 37 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
PTRN PE vs Technology Sector
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
PTRN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.8 | 18% above |
| 20 week MA | $20.8 | 0.7% above |
| 50 week MA | $16.9 | 24% above |
PTRN has stronger trend alignment. PTRN is above 3 of 3 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
PTRN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $15.6 | $11.8 | -24% |
| 2026 YTD | $11.8 | $21.0 | +77% |
PTRN has finished every year since 2025 lower, and it's up 77% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over PTRN on returns for 2026, with the stronger performance.